Key Takeaways
Powered by lumidawealth.com
- Arthur Hayes, co-founder of BitMEX, was pardoned by President Trump after legal troubles related to crypto derivatives trading.
- Hayes is now investing in longevity and biohacking, including a significant stake in a stem cell business with clinics in Mexico and Bangkok.
- He has been a regular patient at these clinics, seeking to extend his healthspan through stem cell infusions.
- Hayes believes stem cell therapy is the future as more countries relax regulations around its use.
- He remains active in crypto, advising firms like Upexi Inc., and is optimistic about the future of digital asset treasury companies (DATs).
- DATs, which hold large crypto balances on their books, are gaining popularity but face challenges in attracting institutional passive index investors.
- Trump’s family is also deeply involved in crypto ventures, including memecoins and crypto mining, despite controversies and price volatility.
- Hayes views Trump’s memecoin launch as a validation of crypto’s growing influence in politics and finance.
What’s Happening?
After a tumultuous legal battle and pardon, Arthur Hayes is pivoting from crypto trading to longevity science and biohacking, while continuing to engage with the crypto ecosystem. His investments and views reflect a broader trend of crypto pioneers exploring new frontiers beyond finance.
Why Does It Matter?
Hayes’s shift highlights the intersection of technology, health, and finance, illustrating how crypto entrepreneurs are leveraging their capital and influence to disrupt traditional industries like biotech. The rise of DATs and political crypto ventures signals evolving dynamics in digital assets and regulatory landscapes.
What’s Next?
Hayes and other crypto leaders will likely continue pushing boundaries in both biotech and digital assets. The success of DATs in attracting institutional capital and the regulatory response to crypto-linked political activities will be key developments to watch.
